Insoluble "fibrin" in human aortic intima. Quantitative studies on the relationship between insoluble "fibrin", soluble fibrinogen and low density lipoprotein
- PMID: 233764
- DOI: 10.1016/0021-9150(76)90116-7
Insoluble "fibrin" in human aortic intima. Quantitative studies on the relationship between insoluble "fibrin", soluble fibrinogen and low density lipoprotein
Abstract
A quantitative assay for fibrin or other insoluble fibrin-like antigens ("fibrin") in small samples of intima is described. Tissue samples were subjected to electrophoresis directly from the intima into an antibody-containing gel to remove and measure fibrinogen and other soluble fibrin reactive antigens (FRA). The residual tissue was then exhaustively incubated with plasmin, and the soluble fragments generated from the insoluble "fibrin" were measured by quantitative immunoelectrophoresis. "Fibrin" accounted for about 2% of the tissue dry weight in normal intima and the ratio fibrinogen/"fibrin" was 1-1.5. In the gelatinous lesions, which seem to be the precursors of fibrous plaques, there was a small increase in "fibrin" but a substantial increase in fibrinogen and low density (LD)-lipoprotein, and the ratio fibrinogen/"fibrin" rose to about 3, which suggests that the increase in "fibrin" is secondary to increased permeation of fibrinogen. At the edges of large plaques there was also a threefold increase in fibrinogen, but "fibrin" increased fivefold, and accounted for 10% of the tissue dry weight. The same high concentration was found in the centres of large fibrous plaques with advanced atheroma lipid. Raised levels of "fibrin" were accompanied by raised levels of fibrinogen in most tissue samples. About 80% of the total soluble FRA could be clotted with thrombin; there was no significant difference between normal intima and lesions, and the proportion clotted was not related to "fibrin" content.
Similar articles
-
Fibrinogen/fibrin in atherogenesis.Eur J Epidemiol. 1992 May;8 Suppl 1:83-7. doi: 10.1007/BF00145356. Eur J Epidemiol. 1992. PMID: 1387095 Review.
-
Molecular interactions in human atherosclerotic plaques.Am J Pathol. 1977 Mar;86(3):665-74. Am J Pathol. 1977. PMID: 65917 Free PMC article.
-
The release of an immobilized lipoprotein fraction from atherosclerotic lesions by incubation with plasmin.Atherosclerosis. 1976 Oct;25(1):71-84. doi: 10.1016/0021-9150(76)90049-6. Atherosclerosis. 1976. PMID: 186079
-
Haemostatic factors in human aortic intima.Lancet. 1981 May 30;1(8231):1171-4. doi: 10.1016/s0140-6736(81)92346-1. Lancet. 1981. PMID: 6112525
-
Fibrinogen, fibrin and the arterial wall.Eur Heart J. 1995 Mar;16 Suppl A:11-4; discussion 14-5. doi: 10.1093/eurheartj/16.suppl_a.11. Eur Heart J. 1995. PMID: 7796823 Review.
Cited by
-
Fibrinogen/fibrin in atherogenesis.Eur J Epidemiol. 1992 May;8 Suppl 1:83-7. doi: 10.1007/BF00145356. Eur J Epidemiol. 1992. PMID: 1387095 Review.
-
The influence of type 2 diabetes on fibrin structure and function.Diabetologia. 2005 Jun;48(6):1198-206. doi: 10.1007/s00125-005-1742-2. Epub 2005 Apr 29. Diabetologia. 2005. PMID: 15864538
-
Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas.Am J Pathol. 1992 Oct;141(4):861-80. Am J Pathol. 1992. PMID: 1415480 Free PMC article.
-
Molecular interactions in human atherosclerotic plaques.Am J Pathol. 1977 Mar;86(3):665-74. Am J Pathol. 1977. PMID: 65917 Free PMC article.
-
Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris.Heart. 1997 Jan;77(1):13-7. doi: 10.1136/hrt.77.1.13. Heart. 1997. PMID: 9038688 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials